Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1279
https://www.valueinhealthjournal.com/article/S1098-3015(15)01336-4/fulltext
Title :
Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01336-4&doi=10.1016/j.jval.2015.03.1279
First page :
A220
Section Title :
Cancer
Open access? :
No
Section Order :
745